Industry Data for Research

Explore Phase Proposal

[Name(s) of the project leader(s) and affiliated institution(s) (university / university of applied sciences)]

[Provisional project title]

Note: This document may be no longer than six pages in length. Please retain the font type, size, page margins and line spacing. The passages in italics are provided for your information only. Please include in your proposal only the section headings printed in bold.

Application Partner
If you have already identified a specific application partner, please indicate this here (company name including full address, contact details and the name(s) of the person(s) responsible for the project). Please enclose a letter of cooperation with the proposal confirming the company’s willingness to conclude a cooperation agreement (in accordance with DFG form 41.026).

If no concrete cooperation with a company is planned as yet, please outline how you intend to initiate cooperation during the 12-month funding period.

[Text]

Field:		□ Health data		□ Mobility data 
Please tick as appropriate

Project Description

1	Problem to be addressed and preliminary work

[Text]

2	Objectives and work programme 

2.1	Objectives
Please describe the scientific and application-oriented objectives of the data cooperation project. What are the milestones you have defined for the Explore phase?

[Text]

2.2	Work programme including handling of research data
Please primarily describe the work planned for the Explore phase and provide information on the data basis of the proposed project. In doing so, please address the following aspects as far as possible: type and scope of the data, documentation and data quality, storage and technical security, legal obligations and regulatory framework, how reuse and long-term accessibility will be enabled, responsibilities and resources. Please describe how the institutions involved in the project will contribute to data and information management. For further information on this topic, see: https://www.dfg.de/en/research-funding/funding-initiative/research-data and the DFG checklist (https://www.dfg.de/resource/blob/174736/92691e48e89bf4ac88c8eb91b8f783b0/forschungsdaten-checkliste-en-data.pdf).

[Text]

3	Project- and subject-related list of publications
This list should only contain your own and third-party publications cited in sections 1 and 2, including the DOI/URL if available. A maximum of ten of your own works cited may be highlighted; font at least Arial 9 pt. 

[Text]

4	Supplementary information 

4.1	Information on the research context and research-related legal aspects
Please indicate which of the aspects listed below apply to the different proposal phases of your planned cooperation project.

		Explore	Exploit	
1.	Involvement of international cooperation partners	<yes / no>	<yes / no>	
2.	Research involving human subjects, human material or identifiable personal data	<yes / no>	<yes / no>	
3.	Research with potential security-relevant aspects in the context of dual-use research of concern	<yes / no>	<yes / no>	

If you have marked any of the above statements with “yes”, please observe any resulting follow-up obligations. The DFG expects the relevant statutory provisions to be complied with. In addition to the above, reference is made to the following guidelines, regulations and laws:
ad 1.	International scientific cooperation is one of the basic principles of research. In the case of cooperation with researchers and application partners outside Germany, please also consider any risks to project implementation and potential for misuse. Where applicable, please explain here how the risk-benefit ratio is to be assessed with regard to the research topic, research and/or application partners and research conditions, and indicate any measures planned to minimise risks. In doing so, take into account the review and reflection aspects listed in the “Recommendations for Dealing with Risks in International Research Cooperation” (https://www.dfg.de/resource/blob/289704/risiken-int-kooperationen-en.pdf).
ad 2.	If a project involves research on humans, identifiable human material or identifiable personal data, a supporting statement is required from the locally responsible ethics committee. The use of human material obtained for diagnostic purposes also requires a statement to be issued by the chair of the ethics committee. A copy of the ethics committee’s approval of the investigations planned for the individual project is to be submitted to the DFG Head Office, if possible along with the proposal. 
ad 3.	Please check whether there are indications in your planned research project that possible research results could produce knowledge, products or technologies that might be directly misused for significant harmful purposes (Dual Use Research of Concern, DURC). For further information, see the DFG website on dealing with risks in security-relevant research.
Projects must comply with foreign trade regulations (especially EC Regulation No. 428/2009 [EC Dual Use Regulation], the Foreign Trade and Payments Act [Außenwirtschaftsgesetz], the Foreign Trade and Payments Ordinance [Außenwirtschaftsverordnung] or embargo regulations) relating to the non-proliferation strategy and the handling of potentially critical goods, including technologies, software and sensitive knowledge transfer; applicants are advised to examine their projects accordingly. Information for researchers is available on the website of the German Federal Office for Economic Affairs and Export Control (BAFA).

4.2	Employment status information
For each applicant, state the last name, first name and employment status (including duration of contract and funding body, if on a fixed-term contract).

[Text] 

4.3	Researchers with whom you have agreed to cooperate on this project
If you will be pursuing your project jointly with researchers working in Germany (shared project leadership), list the names of these individuals in elan under co-investigators. The term co-investigator refers to individuals who are eligible to submit proposals but who neither request nor receive project funding.

[Text]

4.4	Researchers with whom you have collaborated scientifically in the past three years
This information will help avoid potential conflicts of interest.

[Text]

4.5	Project-relevant participation in commercial enterprises
Please indicate if you are the owner of a commercial enterprise or a stakeholder in one (e.g. a director). If so, please state how your research project is linked to the company’s production branch or activities.

[Text]

4.6	Scientific equipment
List any large-scale equipment that will be available to you for the project (e.g. large-scale computing facilities).

[Text]

4.7	Other submissions
Where applicable, inform the DFG of any funding proposals for this project that have been previously submitted to a third party.

[Text]

5	Requested modules
Please explain each requested item. Where there are several applicants, indicate for each item which applicant is requesting it. Modules not listed here cannot be applied for (e.g. investment funds).

5.1	Basic module
Funding for staff and direct project costs required to carry out the project; see module guideline 52.01 for details.

5.1.1	Funding for Staff
The DFG generally grants funding for staff in the form of standard amounts. For rates and other details, please consult the table “DFG Personnel Rates”: www.dfg.de/formulare/60_12

[Text]

5.1.2	Funding for Direct Project Costs

5.1.2.1	Equipment up to €10,000, software and consumables
You may apply for smaller items of equipment required to carry out your project (purchase costs up to €10,000 gross), software and consumables. Contracts awarded to third parties and usage costs for major instrumentation and core facilities are to be applied for under II. 2.5 Other funding.

[Text]

5.1.2.2	Travel Expenses

[Text]

5.1.2.3	Funds for Visiting Researchers

[Text]

5.1.2.4	Other Costs
e.g. contracts awarded to third parties, project-specific instrumentation usage costs and core facilities (see DFG form 55.04 “Guidelines for Instrumentation-Related Usage Costs and Core Facilities” www.dfg.de/formulare/55_04). A quotation must be provided for any costs exceeding €10,000.

[Text]

5.2	Module Temporary Substitutes for Clinicians
Funding for staff to enable the involvement of qualified physicians and psychologists holding a doctorate who perform tasks in patient care; see module guideline 52.04 for details.

[Text]

5.3	Module Project-Specific Workshops
Funding for workshops and colloquia; see module guideline 52.04 for details.

[Text]